A prospective study shows age doesn’t affect survival outcomes in patients with myelodysplastic syndrome (MDS) who receive a hematopoietic cell transplant.
A prospective study shows age doesn’t affect survival outcomes in patients with myelodysplastic syndrome (MDS) who receive a hematopoietic cell transplant.